cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.4530309
title: Data_Table1_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Tab1, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figures as PNG-format (10.1111bph.15367_Tab1.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as two files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_1-2 .csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_1-2_M_1 .txt) in txt format, one file in pdf format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_1-2_M_2 .pdf) and three files containing further related information and general descriptions of the mouse models in use (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_M_1-3 .pdf) as PDF format.
DOI: 10.5281/zenodo.4530108
title: Data_Figure5_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Figure 5, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figures as PNG-format (10.1111bph.15367_Fig5.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as three files in CSV format (31003A_179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_7-8,11 .csv). All further experiment related information provided as two meta-data-file (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_7-8,11_M_1 .txt) in txt format. one file as PDF format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_7-8_M_2.pdf). Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blot as PNG-format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_2_M_3.png), data analysis as one file in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_2.csv) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_1_M_2 .txt). Corresponding raw data and subsequent data analysis obtained from RT-PCR analysis provided as one files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_2.csv), all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_2_M_1 .txt) and one meta data file in pdf format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_2_M_2 .pdf).
DOI: 10.5281/zenodo.4529977
title: Data_Figure4_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Figure 4, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figure as PNG-format (10.1111bph.15367_Fig4.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as five files in CSV format (31003A_179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_5,6,9,10 .csv). All further experiment related information provided as five meta-data-file (31003A_179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_5,6,9,10_M_1 .txt) in txt format. Six files PDF format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_5,6,9,10_M_2.pdf, 31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_10_M_3 .pdf). Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blot as PNG-format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_1_M_2.png), data analysis as one file in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_1.csv) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_1_M_1 .txt). Corresponding raw data and subsequent data analysis obtained from RT-PCR analysis provided as one files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_1.csv), all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_1_M_1 .txt) and one meta data file in pdf format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_1_M_2 .pdf). Corresponding raw data and subsequent data analysis obtained from UV-VIS spectroscopy analysis provided as two files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_17_1-2.csv), all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_17_1-2_M_1 .txt) and one meta data file in pdf format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_17_1-2_M_2 .pdf). Corresponding raw data and subsequent data analysis obtained from scintillation counting analysis provided as three files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_11_1-3.csv), all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_11_1-3_M_1 .txt). One file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_M_1 .pdf) PDF format.
DOI: 10.5281/zenodo.4529506
title: Data_Figure3_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Figure 3, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figures as PNG-format (10.1111bph.15367_Fig3.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as two files in CSV format (31003A_179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_3-4 .csv). All further experiment related information provided as two meta-data-file (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_3-4_M_1 .txt) in txt format and PDF format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_3-4_M_2 .pdf). Three files containing further related information and general descriptions of the mouse models in use (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_M_1-3 .pdf) PDF format.
DOI: 10.5281/zenodo.4529976
title: Data_Figure4_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Figure 4, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figure as PNG-format (10.1111bph.15367_Fig4.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as five files in CSV format (31003A_179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_5,6,9,10 .csv). All further experiment related information provided as five meta-data-file (31003A_179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_5,6,9,10_M_1 .txt) in txt format. Six files PDF format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_5,6,9,10_M_2.pdf, 31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_10_M_3 .pdf). Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blot as PNG-format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_1_M_2.png), data analysis as one file in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_1.csv) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_2_1_M_1 .txt). Corresponding raw data and subsequent data analysis obtained from RT-PCR analysis provided as one files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_1.csv), all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_1_M_1 .txt) and one meta data file in pdf format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_1_1_M_2 .pdf). Corresponding raw data and subsequent data analysis obtained from UV-VIS spectroscopy analysis provided as two files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_17_1-2.csv), all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_17_1-2_M_1 .txt) and one meta data file in pdf format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_17_1-2_M_2 .pdf). Corresponding raw data and subsequent data analysis obtained from scintillation counting analysis provided as three files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_11_1-3.csv), all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_11_1-3_M_1 .txt). One file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_M_1 .pdf) PDF format.
DOI: 10.5281/zenodo.4529505
title: Data_Figure3_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Figure 3, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figures as PNG-format (10.1111bph.15367_Fig3.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as two files in CSV format (31003A_179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_3-4 .csv). All further experiment related information provided as two meta-data-file (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_3-4_M_1 .txt) in txt format and PDF format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_3-4_M_2 .pdf). Three files containing further related information and general descriptions of the mouse models in use (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_M_1-3 .pdf) PDF format.
DOI: 10.5281/zenodo.4529417
title: Data_Figure 2_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Figure 2, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figures as PNG-format (10.1111bph.15367_Fig2.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as two files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_1-2 .csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_1-2_M_1 .txt) in txt format and three files containing further related information and general descriptions of the mouse models in use (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_M_1 .pdf) PDF format.
DOI: 10.5281/zenodo.4529416
title: Data_Figure 2_The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse

description: Data of Figure 2, “The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse” The Dataset (doi:10.1111/bph.15367) contains the original figures as PNG-format (10.1111bph.15367_Fig2.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as two files in CSV format (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_1-2 .csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_4_1-2_M_1 .txt) in txt format and three files containing further related information and general descriptions of the mouse models in use (31003A-179400_10.1111bph.15367_DK_SS_MW_BA_Ratio_Biomarker_M_1 .pdf) PDF format.
DOI: 10.5281/zenodo.4529188
title: Data_Supplemental_Tab2_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids inSerum, Plasma, and Liver Tissue Samples

description: Data of TabS2, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi:10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_TabS2.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as two files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_21-22.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_21-22_M_1 .txt) in txt format and one file containing further related information and general descriptions (31003A-179400_10.3390_metabo10070282_CGC_BAMethod_4_21-22_M_2.pdf) PDF format.
DOI: 10.5281/zenodo.4529187
title: Data_Supplemental_Tab2_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids inSerum, Plasma, and Liver Tissue Samples

description: Data of TabS2, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi:10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_TabS2.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as two files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_21-22.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_21-22_M_1 .txt) in txt format and one file containing further related information and general descriptions (31003A-179400_10.3390_metabo10070282_CGC_BAMethod_4_21-22_M_2.pdf) PDF format.
DOI: 10.5281/zenodo.4529182
title: Data_Supplemental_Tab1_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of TabS1, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi:10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_TabS1.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as eight files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_13-20.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_13-20_M_1 .txt) in txt format and one file containing further related information and general descriptions (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_13-20_M_2.pdf) PDF format.
DOI: 10.5281/zenodo.4529181
title: Data_Supplemental_Tab1_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of TabS1, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi:10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_TabS1.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as eight files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_13-20.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_13-20_M_1 .txt) in txt format and one file containing further related information and general descriptions (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_13-20_M_2.pdf) PDF format.
DOI: 10.5281/zenodo.4529169
title: Data_Supplemental_Figure1_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of Figure S1, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi: 10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_FigS1.PNG). Corresponding raw data and subsequent data analysis obtained from UV/VIS spectroscopy provided as one file in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_17_1-6.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_17_M_1.txt) in txt format and one file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_17_M_2.pdf) PDF format.
DOI: 10.5281/zenodo.4529168
title: Data_Supplemental_Figure1_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of Figure S1, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi: 10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_FigS1.PNG). Corresponding raw data and subsequent data analysis obtained from UV/VIS spectroscopy provided as one file in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_17_1-6.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_17_M_1.txt) in txt format and one file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_17_M_2.pdf) PDF format.
DOI: 10.5281/zenodo.4529161
title: Data_Tab2_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of Tab2, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi: 10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_Tab2.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as three files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_10-12.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_10-12_M_1 .txt) in txt format and two file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_10-12_M_2-3.pdf) PDF format.
DOI: 10.5281/zenodo.4529044
title: Data_Tab1_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of Tab1, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi:10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_Tab1.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as three files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_7-9.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_7-9_M_1 .txt) in txt format and two file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_7-9_M_2-3.pdf) PDF format.
DOI: 10.5281/zenodo.4529160
title: Data_Tab2_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of Tab2, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi: 10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_Tab2.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as three files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_10-12.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_10-12_M_1 .txt) in txt format and two file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_10-12_M_2-3.pdf) PDF format.
DOI: 10.5281/zenodo.4529043
title: Data_Tab1_Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples

description: Data of Tab1, “Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples” The Dataset (doi:10.3390/metabo10070282) contains the original figures as PNG-format (10.3390_metabo10070282_Tab1.PNG). Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis provided as three files in CSV format (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_7-9.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_7-9_M_1 .txt) in txt format and two file containing further related information and general descriptions of the mouse models in use (31003A-179400_10.3390_metabo10070282_CGC_ BAMethod_4_7-9_M_2-3.pdf) PDF format.